Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-facilitated Treatment for Cocaine Use
NCT02037126Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2015
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in cocaine-related disorders, sponsored by University of Alabama at Birmingham. Started May 2015; status: completed.
02
Drugs
psilocybin
03
Conditions
cocaine-related disorders
Beyond the preview
Go deeper on NCT02037126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02037126.